Detalles de la búsqueda
1.
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks).
Breast Cancer Res Treat;
2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38767786
2.
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.
Int J Clin Oncol;
2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38753042
3.
Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.
Int J Clin Oncol;
2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722486
4.
Internal mammary node abnormality in imaging studies and treatment outcomes in patients with breast cancer.
Oncol Lett;
27(5): 218, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38586202
5.
Efficacy and safety of pegfilgrastim biosimilar MD-110 in patients with breast cancer receiving chemotherapy: Single-arm phase III.
Cancer Med;
12(20): 20242-20250, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37824431
6.
A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer.
Breast Cancer Res Treat;
202(3): 485-496, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676450
7.
Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial).
J Immunother Cancer;
11(9)2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37709297
8.
Fulvestrant with or without anti-HER2 therapy in patients in a postmenopausal hormonal state and with ER-positive HER2-positive advanced or metastatic breast cancer: A subgroup analysis of data from the Safari study (JBCRG-C06).
Cancer Med;
12(17): 17718-17730, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37525895
9.
Fosnetupitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Short Review and Clinical Perspective.
Adv Ther;
40(5): 1913-1925, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36884027
10.
Characteristics of Postoperative Patients with Breast Cancer Aged 65 Years and Older.
Curr Oncol;
30(1): 673-680, 2023 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36661701
11.
Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study.
Jpn J Clin Oncol;
53(3): 203-211, 2023 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36484305
12.
Prognosis and effectiveness of chemotherapy for medullary breast carcinoma.
Breast Cancer Res Treat;
196(3): 635-645, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36273358
13.
Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19).
Int J Clin Oncol;
27(11): 1793, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36166110
14.
Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan.
Breast Cancer;
29(6): 985-992, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35733033
15.
Pathological Complete Response Patients after Neoadjuvant Chemotherapy in Breast Cancer.
Acta Med Okayama;
76(2): 105-111, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35503437
16.
Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.
BMC Med;
20(1): 136, 2022 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35462552
17.
Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: a study based on the Japanese National Clinical Database-Breast Cancer Registry.
Breast Cancer;
29(4): 698-708, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35316446
18.
Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative postmenopausal breast cancer: an ad hoc analysis of the JBCRG-C06 Safari study.
Jpn J Clin Oncol;
52(6): 545-553, 2022 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35296894
19.
Frequency and component analysis of contaminants generated in preparation of anticancer agents using closed system drug transfer devices (CSTDs).
Sci Rep;
12(1): 139, 2022 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34996936
20.
Trends in adjuvant therapy after breast-conserving surgery for ductal carcinoma in situ of breast: a retrospective cohort study using the National Breast Cancer Registry of Japan.
Breast Cancer;
29(1): 1-8, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34665435